38
Participants
Start Date
October 21, 2021
Primary Completion Date
December 3, 2025
Study Completion Date
November 3, 2027
Biospecimen Collection
Undergo collection of blood samples
Computed Tomography
Undergo CT scan
Duvelisib
Given PO
Nivolumab
Given IV
Positron Emission Tomography
Undergo PET
Punch Biopsy
Undergo punch biopsies
NYP/Weill Cornell Medical Center, New York
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Emory University Hospital/Winship Cancer Institute, Atlanta
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
Mayo Clinic in Rochester, Rochester
Northwestern University, Chicago
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at Christian Hospital, St Louis
Siteman Cancer Center at West County Hospital, Creve Coeur
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
UCHealth University of Colorado Hospital, Aurora
Mayo Clinic Hospital in Arizona, Phoenix
Mayo Clinic in Florida, Jacksonville
Dana-Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH